Results 31 to 40 of about 11,944 (141)

Attenuation of Experimental Autoimmune Myositis by Blocking ICOS-ICOS Ligand Interaction [PDF]

open access: yesThe Journal of Immunology, 2007
Abstract Polymyositis (PM) is an acquired, systemic, connective tissue disease characterized by the proximal muscle weakness and infiltration of mononuclear cells into the affected muscles. To understand its etiology and immunopathogenesis, appropriate animal model is required. It has been demonstrated that immunization with native human
Yasuhiro, Katsumata   +9 more
openaire   +2 more sources

Factors of Success of Initial Coin Offering. Empirical Evidence from 2016–2019

open access: yesФинансы: теория и практика, 2019
Since 2013, Initial Coin Offerings (ICO) have allowed companies to attract financing with the help of cryptocurrencies. Statistics of ICO shows that the ICO market is increasing and demand for funds continues to grow with claims of over $ 15 billion ...
A. S. Myalo, N. Yu. Glukhov
doaj   +1 more source

Quantum simulation of indefinite causal order induced quantum refrigeration

open access: yesPhysical Review Research, 2022
In the classical world, physical events always happen in a fixed causal order. However, it was recently revealed that quantum mechanics allows events to occur with indefinite causal order (ICO).
Huan Cao   +8 more
doaj   +1 more source

Do It Yourself Ico (Diy Ico) Under $100K

open access: yes, 2018
Founder | Chief Strategy Officer | Blockchain Mind ...
  +5 more sources

Comparative Analysis of ICO, DAOICO, IEO and STO. Case Study

open access: yesФинансы: теория и практика, 2019
The article examines the problem of the ICO (Initial Coin Offering, from English — “initial offer of coins, initial placement of coins”). The information source is the ICO rating data of the return on investment in blockchain startups. The methodological
A. S. Myalo
doaj   +1 more source

ICO vs. Equity Financing under Imperfect, Complex and Asymmetric Information

open access: yesFinTech, 2023
This paper offers a game-theoretic model of a firm that raises funds for financing an innovative business project and chooses between ICO (initial coin offering) and equity financing.
Anton Miglo
doaj   +1 more source

A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral Leishmaniasis in a murine model. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2010
To develop an oral formulation of amphotericin B (AmB) that is stable at the temperatures of WHO Climatic Zones 3 and 4 (30-43 °C) and to evaluate its efficacy in a murine model of visceral leishmaniasis (VL).The stability testing of four novel oral ...
Ellen K Wasan   +8 more
doaj   +1 more source

Tumor Bushcke Lowenstein de crecimiento nnvertido: a propósito de un caso con propuesta terapéutica

open access: yesRevista Colombiana de Gastroenterología
El tumor de Buschke-Löwenstein (TBL) es un tipo de tumor epitelial gigante que se caracteriza generalmente por tener una base ancha con potencial infiltrativo y destrucción a nivel local; por tanto, se producen recidivas frecuentemente, lo cual le ...
Juan Ricardo Márquez Velásquez   +5 more
doaj   +1 more source

DIGITALIZATION OF CRYPTOSPHERE OF THE EAEU COUNTRIES: STATUS AND PROSPECTS

open access: yesВестник университета, 2019
The advantages of cryptocurrency, its distribution and application experience in different countries have been considered. The results of the analysis of the state and ways of development of national and supranational cryptocurrencies in the countries of
O. Makhalina, V. Makhalin
doaj   +1 more source

CLINICAL AND SURVIVAL IMPACT OF FDG PET IN PATIENTS WITH SUSPICION OF RECURRENT OVARIAN CANCER: A 6-YEAR FOLLOW-UP

open access: yesFrontiers in Medicine, 2015
Background: The aim of this retrospective study was to evaluate the contribution of FDG PET to the clinical management and survival outcome of patients (pts) suspected of recurrent ovarian carcinoma, with the hypothesis that early diagnosis of recurrent ...
Daniela eRusu   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy